marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-06-2023
Mirati Therapeutics Cash Flow 2011-2024 | MRTX
Annual Cash Flow Mirati Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-571 M | -389 M | -272 M | -148 M | -70.1 M | -64.7 M | -68 M | -50.7 M | -32.7 M | -29.5 M | -16.6 M | - |
Depreciation & Amortization |
2.93 M | 1.78 M | 641 K | 249 K | 175 K | 184 K | 180 K | 212 K | 199 K | 171 K | 123 K | - |
Accounts Payables |
- | - | - | 16.4 M | 8.53 M | 4.34 M | 6.3 M | 2.1 M | 1.66 M | 1.3 M | - | - |
Accounts Receivables |
865 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
3.02 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Mirati Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -190 M | - | -442 M | - | -160 M | - | -251 M | - | -110 M | - | -195 M | -118 M | -59 M | - | -106 M | -73 M | -34.5 M | - | -49.3 M | -29.1 M | -7.95 M | - | -50.9 M | -35.8 M | -18.2 M | - | -51.9 M | -33.6 M | -17 M | - | -34.7 M | -18.8 M | -9.78 M | - | -24.2 M | -14.5 M | -8.8 M | - | -21.7 M | -16.5 M | -7.34 M | - | -11.5 M | -7.28 M | - | - | - | - | - |
Depreciation & Amortization |
300 K | 300 K | 1.08 M | - | 2.04 M | - | 629 K | - | 1.22 M | - | 294 K | - | 200 K | 100 K | 126 K | - | 156 K | 99 K | 44 K | - | - | 100 K | 41 K | - | - | 91 K | 45 K | - | 139 K | 101 K | 58 K | - | 53 K | 56 K | 44 K | - | 39 K | 38 K | 78 K | - | 41 K | 42 K | 22 K | - | 98 K | 68 K | - | - | - | - | - |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | 18.1 M | 16 M | 24.1 M | 9.59 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 8.53 M | 8.53 M | 8.53 M | 8.53 M | 4.34 M | 4.34 M | 4.34 M | 4.34 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.75 M | 1.75 M | 1.75 M | - | - | - | - | - |
Accounts Receivables |
14.7 M | 10.5 M | 6.23 M | 865 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
20.2 M | 8.64 M | 3.85 M | 3.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency